DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 38 filers reported holding DECIBEL THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $770,000 | +0.5% | 200,000 | -21.2% | 0.18% | +20.5% |
| Q1 2023 | $766,530 | +38.5% | 253,818 | -6.0% | 0.15% | +32.5% |
| Q4 2022 | $553,500 | -46.7% | 270,000 | -10.0% | 0.11% | -50.0% |
| Q3 2022 | $1,038,000 | -20.5% | 300,000 | -3.2% | 0.23% | -7.7% |
| Q2 2022 | $1,305,000 | – | 310,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $9,545,000 | 2.59% |
| Samsara BioCapital, LLC | 826,422 | $2,512,000 | 0.63% |
| Orbimed Advisors | 4,945,192 | $15,033,000 | 0.24% |
| Alphabet Inc. | 1,636,258 | $4,974,000 | 0.16% |
| HARVARD MANAGEMENT CO INC | 328,798 | $1,000,000 | 0.10% |
| Casdin Capital, LLC | 330,000 | $1,003,000 | 0.04% |
| Bronte Capital Management Pty Ltd. | 163,224 | $496,000 | 0.04% |
| MYDA Advisors LLC | 20,000 | $61,000 | 0.02% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 263,600 | $801,000 | 0.02% |
| ATLAS CAPITAL ADVISORS LLC | 41,025 | $124,716,000 | 0.02% |